Terms: = Liver cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
213 results:
1. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors - a systematic review and meta-analysis.
Dawood ZS; Brown ZJ; Alaimo L; Lima HA; Shaikh C; Katayama ES; Munir MM; Moazzam Z; Endo Y; Woldesenbet S; Pawlik TM
HPB (Oxford); 2024 May; 26(5):618-629. PubMed ID: 38369433
[TBL] [Abstract] [Full Text] [Related]
2. HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis.
Mezzacappa C; Mahmud N; Serper M; John BV; Taddei TH; Kaplan DE
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055642
[TBL] [Abstract] [Full Text] [Related]
3. A Modification of the American Joint Committee on cancer Nomogram for Undifferentiated Sarcoma With External Validation and Risk Stratification.
Yuan J; Zhang X; Zhang S; Yu S
Am Surg; 2024 Apr; 90(4):762-769. PubMed ID: 37905507
[TBL] [Abstract] [Full Text] [Related]
4. Role of TOP2A and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract] [Full Text] [Related]
5. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy.
Shi S; Zhao YX; Fan JL; Chang LY; Yu DX
Acad Radiol; 2023 Dec; 30(12):2940-2953. PubMed ID: 37798207
[TBL] [Abstract] [Full Text] [Related]
6. Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study.
Yang F; Gao L; Wang Q; Gao W
Cancer Control; 2023; 30():10732748231202953. PubMed ID: 37776257
[TBL] [Abstract] [Full Text] [Related]
7. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
[TBL] [Abstract] [Full Text] [Related]
8. A predictive scoring model to select suitable patients for surgery on primary tumor in metastatic esophageal cancer.
Wei L; Xu J; Hu X; Xie Y; Lyu G
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1898. PubMed ID: 37702247
[TBL] [Abstract] [Full Text] [Related]
9. Global Analysis of Endogenously Intact S-Acylated Peptides Reveals Localization Differentiation of Heterogeneous Lipid Chains in Mammalian Cells.
Ji G; Wu R; Zhang L; Yao J; Zhang C; Zhang X; Liu Z; Liu Y; Wang T; Fang C; Lu H
Anal Chem; 2023 Sep; 95(35):13055-13063. PubMed ID: 37611173
[TBL] [Abstract] [Full Text] [Related]
10. Sugar-Sweetened and Artificially Sweetened Beverages and Risk of liver cancer and Chronic liver Disease Mortality.
Zhao L; Zhang X; Coday M; Garcia DO; Li X; Mossavar-Rahmani Y; Naughton MJ; Lopez-Pentecost M; Saquib N; Shadyab AH; Simon MS; Snetselaar LG; Tabung FK; Tobias DK; VoPham T; McGlynn KA; Sesso HD; Giovannucci E; Manson JE; Hu FB; Tinker LF; Zhang X
JAMA; 2023 Aug; 330(6):537-546. PubMed ID: 37552302
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it's not all about size.
Kolck J; Auer TA; Walter-Rittel T; Hosse C; Elkilany A; Marth AA; Pelzer U; Mohr R; Krenzien F; Lurje G; Schöning W; Hamm B; Geisel D; Fehrenbach U
Abdom Radiol (NY); 2023 Oct; 48(10):3063-3071. PubMed ID: 37354262
[TBL] [Abstract] [Full Text] [Related]
12. Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Lei Z; Ma W; Si A; Zhang Y; Yang F; Yu Q; Tang H; Xiao Q; Zhou J; Wang K; Tang Y; Han T; Yin G; Chen J; Liu X; Zhao H; Yu D; Luo T; Wang Q; Yan M; Mao X; Li J; Wang K; Li J; Zeng Y; Ding D; Chen T; Wu X; Xia Y; Wang K; Guo W; Zhu G; Gao S; Hüser N; Lau WY; Song T; Cheng S; Shen F; Cheng Z
Aliment Pharmacol Ther; 2023 Sep; 58(6):611-622. PubMed ID: 37349908
[TBL] [Abstract] [Full Text] [Related]
13. A gadoxetic-acid enhancement flux analysis of small liver nodules (≤2 cm) in patients at high risk of hepatocellular carcinoma.
Chen H; Wang J; Guo T; Ye T; Wan J; Sun P; Pan F; Yang L
Eur J Radiol; 2023 Aug; 165():110911. PubMed ID: 37300937
[TBL] [Abstract] [Full Text] [Related]
14. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
[TBL] [Abstract] [Full Text] [Related]
15. Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS).
Teramura S; Yamagishi K; Umesawa M; Hayama-Terada M; Muraki I; Maruyama K; Tanaka M; Kishida R; Kihara T; Takada M; Ohira T; Imano H; Shimizu Y; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H
J Atheroscler Thromb; 2023 Oct; 30(10):1483-1491. PubMed ID: 36878531
[TBL] [Abstract] [Full Text] [Related]
16. Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
Xin HY; Sun RQ; Zou JX; Wang PC; Wang JY; Ye YH; Liu KX; Hu ZQ; Zhou ZJ; Fan J; Zhou J; Zhou SL
JAMA Netw Open; 2023 Mar; 6(3):e231476. PubMed ID: 36867406
[TBL] [Abstract] [Full Text] [Related]
17. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study.
Yoo TK; Lee MY; Kim SH; Zheng MH; Targher G; Byrne CD; Sung KC
Nutr Metab Cardiovasc Dis; 2023 May; 33(5):947-955. PubMed ID: 36746687
[TBL] [Abstract] [Full Text] [Related]
19. Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study.
Chen B; Zhang L; Cheng J; Wu T; Lei J; Yang X; Zhang R; Safadi R; Li Y; Si T; Lu Y
Drug Des Devel Ther; 2022; 16():4429-4437. PubMed ID: 36597443
[TBL] [Abstract] [Full Text] [Related]
20. Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Famularo S; Donadon M; Cipriani F; Fazio F; Ardito F; Iaria M; Perri P; Conci S; Dominioni T; Lai Q; La Barba G; Patauner S; Molfino S; Germani P; Zimmitti G; Pinotti E; Zanello M; Fumagalli L; Ferrari C; Romano M; Delvecchio A; Valsecchi MG; Antonucci A; Piscaglia F; Farinati F; Kawaguchi Y; Hasegawa K; Memeo R; Zanus G; Griseri G; Chiarelli M; Jovine E; Zago M; Abu Hilal M; Tarchi P; Baiocchi GL; Frena A; Ercolani G; Rossi M; Maestri M; Ruzzenente A; Grazi GL; Dalla Valle R; Romano F; Giuliante F; Ferrero A; Aldrighetti L; Bernasconi DP; Torzilli G;
JAMA Surg; 2023 Feb; 158(2):192-202. PubMed ID: 36576813
[TBL] [Abstract] [Full Text] [Related]
[Next]
